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Introduction: Mental health, physical health and cognitive skills have been scarcely investigated 
in the same sample of adults with PKU (AwPKU). This is striking since emotional difficulties 
may potentially contribute to cognitive impairments and vice-versa. Here we aim to fill this gap. 
Method: Thirty-six early-treated AwPKU and 40 controls were given an extensive battery of 
cognitive tasks assessing complex executive functions, inhibitory control, short –term-memory, 
sustained attention, visuospatial attention, language production (reading and naming), visuo-
motor coordination, spoken language and orthographic processing.   In addition, participants 
were given tasks tapping emotion recognition and completed questionnaires to assess depression 
(BDI-II), empathy (IRI) and mental/physical health-related quality of life (SF-36).  
Results: As a group, AwPKU performed significantly worse than controls especially in tasks 
tapping complex executive functions and across tasks when speed was measured but did not 
differ for emotional-health and physical health. In the PKU group, cognitive measures and 
measures of physical health- related quality of life were inter-correlated (differently than in the 
control group), and both measures were associated with metabolic control: better metabolic 
control, better cognition and better physical health.  Instead, cognitive measures and measures of 
emotional-health/ mental-health related quality of life did not correlate with one another and 
better metabolic control was not associated with better emotional health.    Instead, some 
negative correlations were found.  Better metabolic control was associated with worse 
perspective taking and more distress in socially stressful situations.  Furthermore, difficulties in 
keeping the diet were associated with less emotional well-being. 
Conclusions: Taken together, these results indicate the advantages, but also possible emotional 









Phenylketonuria (PKU; ORPHA716) is a rare inherited metabolic disease caused 
by mutations on chromosome 12 in the gene coding for the phenylalanine hydroxylase 
enzyme (PAH). Normally, PAH converts the amino acid phenylalanine (Phe) into 
tyrosine, but in PKU a PAH deficiency disrupts this process. This causes accumulation of 
Phe in the blood, leading to toxic concentrations in the brain as well as a lack of tyrosine 
and possibly a lack of dopamine, of which tyrosine is a precursor (Boot et al., 2017; 
Burlina et al., 2000; McKean, 1972, Puglisi-Allegra et al., 2000). Consequently, untreated 
PKU results in severe intellectual disabilities, microcephaly and seizures (Blau, van 
Spronsen, & Levy, 2010).  From the 1970s, detection through neonatal screening 
programs and early treatment with a low-protein diet has prevented severe neurological 
damage and mental disabilities.  
Despite early treatment, however, individuals with PKU show some mild 
cognitive impairments (for a review see Christ, Huijbregts, de Sonneville, & White, 
2010; Hofman, Champ, Lawton, Henderson, & Dye, 2018; Janzen & Nguyen, 2010; 
Moyle, Fox, Arthur, Bynevelt, & Burnett, 2007; Palermo et al., 2017; Romani et al., 
2017).  In both children and adults with PKU, the most common cognitive deficits include 
a reduction in speed of processing, especially in visuo-attentional tasks, and impairments 
in higher-order executive functions (e.g., Albrecht, Garbade, & Burgard, 2009; De Roche 
et al., 2008; Romani, MacDonald, De Felice, & Palermo, 2018; Romani et al., 2019). 
Regarding the influence of blood phenylalanine control on cognitive performance, 
processing speed is strongly associated with Phe levels in childhood, but this association 






Bynevelt, Arthur, & Burnett, 2007; Romani et al., 2017;  for a meta-analysis, see 
Albrecht et al., 2009).  In contrast, current Phe levels in adulthood seem to be particularly 
important for sustained attention (Romani et al., 2017; Schmidt et al., 1994; Ten Hoedt et 
al., 2011) and learning (Romani et al., 2017; Smith, Klim, Mallozzi, & Hanley, 1996), 
but results so far are limited.  
Emotional and behavioural difficulties clearly co-occur with cognitive 
impairments in untreated individuals with PKU (Brumm, Bilder, & Waisbren, 2010; 
Wood, Friedmann, & Steisel, 1967).  Difficulties in early-treated children and adolescents 
have also been reported (for a review see Brumm et al., 2010; see also Jahja et al., 2013; 
Weglage, Fünders, Ullrich, Rupp, & Schmidt, 1996; Weglage et al., 2000), but not 
consistently (e.g., see Sullivan, 2001, who did not report differences in psychiatric 
disorders and emotional symptoms among:  a). adolescents with PKU, b). adolescents 
with a chronic illness and c). controls).    Fewer studies have investigated the presence of 
mental health problems in AwPKU and possible relationships with Phe levels with 
conflicting results.  A number of these studies have reported no significant difficulties 
(e.g., Channon, German, Cassina, & Lee, 2004; Channon et al., 2005; Channon, 
Goodman, Zlotowitz, Mockler, & Lee 2007; Ris et al., 1997). Other studies, however, 
have suggested possible mental health difficulties, and, especially, a higher incidence of 
internalizing symptoms (i.e. more depression, social isolation, and anxiety), but a normal 
incidence of externalizing symptoms (negative behaviours towards the external 
environment, such as aggression; see Bilder et al., 2013; Jahja et al., 2017a,b; Manti et 
al., 2016; Pietz et al., 1997).  Even in studies reporting a higher incidence of mental 
difficulties in AwPKU, however, correlations with Phe levels often either have not been 






example, Jahja et al. (2017a) found that adults with childhood Phe ≥ 360 µmol/L had 
poorer mental health in terms of depressive and somatic symptomatology that those with 
childhood Phe < 360 µmol/L.   However, Pietz et al. (1997) found no correlation between 
rate of internalizing symptoms and Phe levels across ages (childhood, 12 years to 
adulthood, recent levels, and concurrent levels).  Instead, a restrictive controlling style of 
parenting was a risk factor.  Similarly, Manti et al. (2016) found that mental health was 
not associated with life-long and concurrent quality of metabolic control, nor with Phe 
fluctuations.  Instead, paradoxically, individuals with better metabolic control (≤500 μM) 
in the first 11 years of life showed higher frequency of psychiatric diagnosis than patients 
with worse control.   
It is possible that mental health problems in children and adults with PKU, if at all 
present, are more the consequence of the stress of growing-up and living with a chronic 
disease than of having high Phe levels (see also Crone et al., 2005 for an association 
between parenting styles and dietary control and the advocacy to develop efficient 
strategies to make children adhere to the diet without being too rigid).   Moreover, rather 
than being directly related to Phe, levels emotional difficulties may be related to 
cognitive difficulties. Deficits in speed or processing and/or executive functions 
(planning, problem solving, working memory, sustained attention) may reduce someone’s 
ability to cope with daily life demands and this, in turn, may create mental health 
difficulties. The opposite may also be true. We know that cognitive performance could be 
affected by depression, anxiety and poor self-esteem (Marazziti, Consoli, Picchetti, 
Carlini, & Faravelli, 2010).  These relationships are worth exploring, but, so far, only few 
studies have examined them, with especially few studies targeting adults with PKU (Jahja 






relationship with mental health have been examined only in terms of IQ and few other 
functions, with mixed results. Ris et al. (1997) found significant correlations between 
cognitive measures (IQ, Wisconsin Card Sorting Test, and attention) and mental health 
measured, but these results were not replicated by further studies. Pietz et al. (1997) did 
not find any relationship between IQ and mental health variables (in terms of severity or 
frequency of psychiatric symptoms) assessed with four scales tapping antisocial 
behaviour, functional and emotional behaviour (e.g. depressed mood, anxiety), emotional 
instability and specific symptoms (e.g. tics, stereotypes). Jahja et al. (2017a) found that 
AwPKU had poorer mental health than controls, even when IQ was included as a 
covariate.    Finally, Manti et al. (2016) did not find significant correlations between IQ 
and psychiatric assessment scores, although patients with an IQ ≥ 85 reported less mental 
health problems than patients with an IQ < 85.  
 Finally, it is important to assess how cognitive ability and mental health relate to physical 
health and possible mediating associations with Phe.  Most of studies have not shown a higher 
incidence of medical issues in PKU using the physical health related quality of life questionnaire 
(pHRQoL). Landolt, Nuoffer, Steinmann, and Superti-Furga (2002) and Cazzorla et al. (2014) 
did not find a higher incidence of pHRQoL problems in children and adolescents with PKU. 
Similarly, studies with AwPKU generally failed to detect pHRQoL issues (Bosch et al., 2007; 
Cazzorla et al., 2014; Channon et al., 2007, Simon et al., 2008).  Only Bosch et al. (2015), using 
the PKU-specific health related quality of life questionnaire (PKU-QOL), showed that children, 
adolescents and adults with PKU reported tiredness more frequently than expected.   Only 
limited and mixed information is available on relationship with Phe levels. Landlot et al. (2002) 
did not find any association with Phe level in the first year of life or in the 12 months before 






life and Phe level at time of testing and in the 12 months beforehand.  Channon et al. (2007) did 
not find any difference between on diet and off diet adults with PKU on pHRQoL, but Koch et 
al. (2002) found more medical issues, such as headaches, eczema and neurological signs.   No 
studies that we know of have examined an interrelation between cognitive performance and 
physical health difficulties. 
 In the present study, we aim to evaluate, in AwPKU, possible inter-relationships among 
a) cognitive abilities, b) mental health and c) physical health and relationships between each of 
these variables and Phe concentrations during the life span. To reduce error and increased the 
reliability of our results, we have used a range of measures for each of these domains.  There is 
consistency in the PKU literature about which measures are correlated.  This depends at least in 
part different measures being used to tap the same function in different studies (e.g., see Hofman 
et al., 2018).  Tasks and questions in a questionnaire are no uniquely linked to single a 
cognitive/emotional/physical function and different researchers have their preference.  Another 
important factor, however, is that individual correlations are notoriously unreliable especially in 
the range of sample sizes used in the PKU literature (typically N < 50).  To address these 
difficulties, our analysis will not rely on the significance of individual correlations, but instead 
will consider pools of correlations and consider whether they provide evidence for a give 
association when considered together (see section on data analysis).  This both reduces any 
personal bias in the choice of tasks/measures and, more importantly, reduces the error linked to 
variability in individual correlations.   
Cognitive abilities were evaluated in terms of an comprehensive set of indices 
tapping: 1. Complex executive functions (from now on EF); 2. Inhibitory control; 3. 
Short-term/working memory; 4. Sustained attention, 5. Visuo-spatial attention speed; 6. 






Orthographic processing accuracy; 10. Spoken language accuracy; 11. Verbal learning 
and memory; 12 Visuo-spatial memory and learning (similar indexes were used in 
Palermo et al., 2017).  
 Emotional health was evaluated using questionnaires on depression, empathy, 
and quality of life related to mental health.  Depression is important to examine because 
of reports of pathological increases in PKU and because of a potential relationship with 
cognitive performance.  Empathy is important to examine because of its central role in 
social/personal relationships, which in turn are crucial for mental health.  Moreover, both 
depression and pro-social-empathic abilities have been linked to the functioning of the 
dopaminergic system which may be affected in PKU.  The mesolimbic dopamine 
pathway has been implicated in the control of mood (hypoactivity is related to altered 
reward processing and anhedonia, see Kulkarni & Dhir, 2009; Leggio et al., 2013) and 
dopamine has been argued to be important for the functioning of the “social brain” 
(Skuse & Gallagher, 2009) and, particularly, for empathy-motivated prosocial behaviour 
(Preston, 2013; Uzefovsky et al., 2014). 
As a possible intermediate variable between cognitive performance and mental 
health, we assessed facial emotion recognition.  There is a report of people with PKU 
showing difficulties in this domain (Jahja et al., 2016).  Difficulties recognizing facial 
emotions may reduce empathy and, more generally, create difficulties with social 
interactions.  This, in turn, may impact on mental health. (for a review see Kohler, 
Turner, Gur, & Gur, 2004).  Facial emotional recognition was evaluated with three 
subtests from the Comprehensive Affect Test System (CATS; Froming, Levy, Schaffer, 






Physical health was evaluated with a commonly used questionnaire assessing 
quality of life related to physical health. Phe concentrations were assessed both in terms 
of mean levels and Phe fluctuations since fluctuations have been found to be linked to 
cognitive performance both in our group of AwPKU (Romani et al., in press ) and in 
children groups (Burgard et al., 1996; Arnold et al., 1998; Vilaseca et al., 2010; Hood, 
Grange, Christ, Steiner, & White, 2014; see for a review Cleary et al., 2013). Finally, we 
assessed attitudes towards diet in terms of deemed importance and ease of following it.   
 
Materials and Methods 
Participants 
Early-treated patients with classical PKU were recruited from a pool of 88 individuals 
followed by the Department of Inherited Metabolic Disorders at the University Hospitals 
Birmingham who had been treated with a low-Phe diet since diagnosis in infancy and were still 
contactable. A total of 42 AwPKU responded to the invitation and consented to be tested. For six 
of them none of the mental health/emotion recognition measures were available, leaving a final 
sample of 36 participants.  Diagnosis with newborn screening was at 5-7 days after birth. At the 
time of testing six AwPKU were on an unrestricted diet and 30 were still on a low-protein diet. 
The AwPKU were compared to a group of 40 healthy controls matched for age, gender, and 
education. Healthy volunteers were recruited through the Aston University volunteering website. 
Data on historical Phe concentrations were obtained from the PKU database at The Clinical 
Chemistry Department at the Birmingham Children's Hospital.  Our experimental groups have a 
strong overlap with those reported in our previous studies: 31/36 AwPKU and 30/40 controls are 






solely on cognitive functions and did not report on emotional processing and on questionnaire-
derived measures of mental and physical health. 
Table 1 reports demographic and metabolic information.  Phe measures are reported as 
average Phe levels and Phe fluctuations at different ages. The average Phe level in each age band 
was calculated by averaging the mean Phe levels of each year and then averaging across the 
years in the age band.  Similarly, Phe fluctuation in each age band is the average of the standard 
deviations of each year in the age band.  Results show that Phe levels were well controlled in 
childhood, but diet was progressively relaxed after early childhood with increasingly high blood 
Phe levels, but not increasing fluctuations.  Numbers are small, but AwPKU and controls did not 
differ in the frequency of unemployment or, for the people employed, in yearly salary.  
Similarly, AwPKU and controls did not differ for number of individuals in a stable relationship 
(64.7% vs. 46.7%; (χ2(1) = 2.1; p = .14) or being a parent (17.6% vs. 23.3% with one or more 
children; χ2(1) = .2; p = .61). Overall, these data indicate that AwPKU as a group are highly 
functional. 
--------------------------------- 
Insert Table 1 about here 
---------------------------------- 
 
Participants were tested in a quiet room in three separate testing sessions, two lasting 
approximately three hours and one lasting one hour.  Blood Phe concentrations were measured 
on the morning of each testing session to determine current Phe levels. All participants gave 
voluntary informed consent to take part in the research that was approved by the NHS and Aston 
University Ethics committees. All efforts were made to administer all tasks to all participants, 






of failure to schedule another appointment for personal reasons and lack of resources on the part 
of the research team).   
Assessment 
Cognitive Abilities 
IQ was measured using the Wechsler Abbreviated Scale of Intelligence (WASI; 
Wechsler, 1999). In addition, participants were given an extensive neuropsychological battery 
providing 28 different cognitive measures (described in more detail in Palermo et al., 2017). To 
facilitate report, z-scores from similar measures and/or from tasks in similar domains were 
aggregated into single scores (see also Arnold et al., 1998; Griffiths, Paterson, & Harvie, 1995; 
Nardecchia et al., 2015, Romani et al., 2017 for similar methodologies).  The different domains 
considered by our study and relative tasks are described below1.   
Complex executive functions were calculated by averaging the z scores for the following four 
measures/tasks: 
1. The Tower of Hanoi puzzle (Shallice, 1982): move rings of different sizes from an initial 
peg across three pegs to form a tower on the last peg; specific constraints have to be 
followed. Our score is based on the percentage of solved trials of different complexity 
(with three, four, and five rings). 
2. The Wisconsin Card Sorting Test (Kongs, Thompson, Iverson, & Heaton, 2000): discover 
which rule to follow to match cards from a deck with four reference cards (e.g., 
according to shape, number or colour) using feedback.  Our score aggregates different 
measures form the 64 Cards Version.   
                                                          
1 Measures were aggregated following classical neuropsychological categories (e.g., visuo-
spatial memory, verbal memory). EF measures were subdivided considering a commonly 






3. Semantic Fluency (Rosen, 1980): say as many animals as possible in one minute of time. 
4. Trail Making Test B-A (Reitan, 1958). This measures the difference between the time it 
takes participants to connect alternating number and letter circles (Trail Making B) and the 
time it takes to connect circles containing only numbers (Trail Making A). 
Inhibitory Control was calculated by averaging the z scores for the following two 
measures/tasks:  
1. The Stroop colour–word test: Interference (Stroop, 1935). This measured the difference in 
both time and errors between reporting the ink colour of coloured words where the colour 
of the ink was either incongruent with the meaning of the word (e.g. ʽred’ written with 
yellow ink), or congruent with the meaning of the word (e.g. ʽred’ written with red ink). 
2. Picture naming: Semantic interference. This measured the differences in both RT and 
error rates between naming the first and last exemplar of a series of semantically related 
nouns.   
Short-term memory memory was calculated by averaging the z scores for the following three 
tasks 
1. Digit Span; repeat a sequence of digits spoken by the examiner, immediately after 
presentation).  
2. Nonword Repetition (Romani, Tsouknida, & Olson, 2015): repeat a sequence of 
nonwords spoken by the examiner, immediately after presentation).  
3. Corsi Block Span (Corsi, 1972): the examiner taps a sequence of blocks and the 
participant has to reproduce the sequence in the same order. 
Sustained attention was measured using the Rapid Visual Information Processing (RVP) task 
(adapted from Sahakian, Jones, Levy, Gray, & Warburton, 1989) in which the participant must 






digits are presented on the computer screen and the participant has to press the response key 
when the last number of the sequence appears on the screen.  The score is the percentage of 
correct responses. 
Visuo-spatial attention-speed was calculated by averaging the z scores for mean correct RTs in 
the following six tasks: 
1. Simple Reaction Time: press a button as soon as a ladybird appears on the screen.  
2. Detection with distractors: press a button whenever a ladybird appears on the screen alone or 
with a green bug.  
3. Opposite Detection with distractors: press a button whenever a green bug appears on the 
screen alone or with a ladybird.  
4. Choice Reaction Time (from Cambridge Neuropsychological Test Automated Battery, 
CANTAB): press either a left or right response key, consistent with the direction of an arrow 
presented centrally.  
5. Feature Search: detect a target among distractors not sharing features by pressing a ʽyes’ or 
ʽno’ button (e.g. a red ladybird among green bugs).  
6. Conjunction Search: detect a target among distractors sharing features (e.g. red ladybird 
among red bugs and green ladybirds). 
Visuo-spatial attention-accuracy was calculated by averaging accuracy z scores in Detection 
with distractors, Opposite Detection with distractors, Choice Reaction Time, Feature Search and 
Conjunction Search tasks described above (simple Detection excluded because of lack of errors 
Language production -speed was calculated by averaging the z scores for mean correct RTs in 
the following four tasks: 
1. Word Reading (adapted from Romani et al., 2015): read an English word as fast as possible.  






3. Picture Naming: name a picture as fast as possible.  
4. Colour Naming: name, as fast as possible, the ink colour of a sequence of ʽX’ letters (i.e. 
XXX) or coloured words where the colour of the ink matched the meaning of the word (e.g. 
‘red’ written with red ink). 
Spoken language accuracy. This was calculated by averaging the accuracy z scores for the 
following four tasks:  
Picture naming: name a picture as fast as possible;  
1. Color naming: name as fast as possible the ink color of three X’s or colored words; only the 
congruent condition is considered here where the color of the ink matched the meaning of the 
word, for example, red written with red ink; 
2. Similarities from the WASI (Wechsler, 1999): describe how similar in meaning two words 
are;  
3. Vocabulary from the WASI (Wechsler, 1999): define a word. 
Orthographic processing-accuracy. This was calculated by averaging the accuracy z scores for 
the following four tasks (phoneme deletion and spoonerisms are included in this index since they 
are strongly related to orthographic abilities):  
1. Word reading and Nonword reading (adapted from Romani et al., 2015): read an English 
word/non-word as fast as possible (error rates was taken); 
2. Word Spelling and Nonword spelling (Romani et al., 2015): spell words/nonwords to 
dictation; 
3. Phoneme deletion: delete a sound from a word (e.g., powder; /d/ power); 
4. Spoonerisms (adapted from Romani et al., 2015): exchange the initial sounds of two words to 






Visuo-spatial memory and learning was calculated by averaging the z scores of the following 
measures/tasks: 
1. Delayed Matching to Sample (DMS; adapted from Sahakian et al., 1988): recognize a 
previously seen pattern among distracters.  
2. Paired Associates Visual Learning (PAL; adapted from Sahakian et al., 1988): learn the 
association between objects and locations on the computer screen.  
Verbal memory and learning was calculated by averaging the z scores of the following 
measures/tasks: 
1. The Rey Auditory Verbal Learning Test (Rey, 1964; Schmidt, 1996) entailed learning, 
immediate recall and delayed recall of a list of 15 words.  
2. Paired Associates Verbal Learning (Romani et al., 2015) involved learning and delayed 
recall of a nonword associated with the picture of an object or animal. 
Visuo-motor coordination was calculated by averaging the z scores of the following tasks: 
1. Digit Symbol (Wechsler, 1997): the participant is given 90 seconds to fill as many boxes as 
possible with symbols corresponding to number according to a key.  
2. Grooved Pegboard Test (Trites, 1977): put pegs into the holes of a board as quickly as possible 
using only one hand.  
 
Emotional Health and mental health-related quality of life 
Emotional health and mental health-related quality of life were assessed with three types of 
standardized questionnaires. 
The Beck Depression Inventory II (BDI-II; Beck, Steer, & Brown, 1996) evaluates the 
presence of depression. It includes 21 items, with each item assessing a specific symptom of 






participant must select which statement best applies to how he has been feeling in the last two 
weeks.  Statements are graded for severity on a 0-3 scale for a maximum total score of 63. 
According to the standardized cut-offs, scoring 0–13 indicates minimal depression, 14–19 mild 
depression, 20–28 moderate depression, and 29–63 severe depression.  
The Interpersonal Reactivity Index (IRI; Davis, 1980) evaluates empathy.  It consists 
of four seven-item subscales.  1. The Perspective-Taking subscale assesses the tendency to adopt 
the point of view of other people; 2. the Fantasy subscale measures the tendency to identify with 
fictional characters; 3. the Empathic Concern subscale measures feelings of warmth, 
compassion, and concern for others, and 4. the Personal Distress subscale measures personal 
feelings of anxiety and discomfort in tense interpersonal situations. The Empathic Concern and 
the Personal Distress subscales assess affective aspects of empathy while the Perspective-Taking 
and the Fantasy subscales assess cognitive aspects. Participants had to rate how well each item of 
the scale described them using a 5-point Likert scale, ranging from 0 (doesn’t describe me at all) 
to 4 (describes me very well).   High scores on the Perspective-Taking, Fantasy and Empathic 
Concern subscales are associated with a pro-social tendency (a greater ability to take someone 
else's perspective being associated with more concern for others).  Scores on these scales 
increase from childhood to adulthood.  High scores on Personal Distress, instead, are associated 
with emotional difficulties (e.g., social anxiety and neuroticism) and scores consistently decrease 
with age (Batson, Early, & Salvanari, 1997; De Corte et al., 2007; Davis & Franzoi, 1991; 
Eisenberg & Eggum, 2009; for the Fantasy subscale see Hawk et al., 2013).    
The Mental Health Quality of Life scale from SF-36 (Ware, Snow, Kosinski, & 
Gandek, 1993) assesses mental health-related quality of life (Farivar, Cunningham, & Hays, 
2007).  It includes four subscales assessing: 1. Vitality, 2. Social functioning, 3. Role limitations 






questions assessed on a 5/6-point Likert scale and three dichotomous (yes-no) questions. For 
each subscale, scores range from 0 to 100 with higher scores reflecting a better health state.  
 
Emotion Recognition 
This was investigated with three subtests from the Comprehensive Affect Test System (CATS; 
Froming, Levy, Schaffer, & Ekman, 2006), which uses stimuli from Ekman's internationally-
normed faces collection. The Identity Discrimination subtest asks participants to decide if two 
faces represent the same or different individuals (22 trials with emotionally neutral faces) in 
order to exclude problems in face processing.  The Three Faces Test asks participants to select 
the two portraits that express the same emotion (36 trials). The Select Affect Test asks 
participants to match the written name of an emotion with one out of five faces expressing 
different emotions (20 trials).  For all subtests, we recorded number of correct answers and 
response latencies.    
 
Physical health-related quality of life 
This was examined with The Physical Health Quality of Life scale from SF-36 (Ware et al., 
1993) which comprises the following four sub-scales: 1. Physical function, 2. Role limitations 
due to physical health problems, 3. Bodily pain, 4. General health.  This scale includes 18 
questions assessed on a 3/6-point Likert scales and four dichotomous (yes-no) questions. For 
each subscale, scores range from 0 to 100 with a higher score reflecting a better health state.  The 
questionnaire was scored as suggested in Hays, Sherbourne & Mazel (1993). The scoring 









We will assess differences between the PKU and the control group with t-tests. 
We will measure associations between different measures through bivariate Pearson r 
correlations.   To facilitate interpretation, in all our analyses and for all our measures, higher 
scores will reflect better performance.  We will refer to correlations as ‘positive’ if they meet 
expectations and better scores for one measure are associated with better scores in the other 
measure. We will refer to correlations as ‘negative’ if their value is in the opposite than expected 
direction.   
 Crucially, in order to assess associations of interest in a more reliable way, we will 
consider patterns of correlations in a given domain (1. cognitive-health, 2. emotional-health or 3. 
physical health) as well as compare patterns across domains. For this purpose, we will carry out 
three types of analyses.   
1. Within each domain, we will:  
a. With2s, compare the rate of positive vs negative correlations relative to a chance 50/50 
rate; if there is an association, the rate of positive correlations will be significantly higher 
than chance, independently of whether any individual correlation reaches a significant 
difference from 0;  
b. As above, compare the rate of positive vs negative significant correlations; if there is a 
real association, the rate of significant positive correlations will be higher.  Instead, if 
there is no real association --and the significant correlations are obtained by chance--, 
significant positive correlations will be counter-balanced by an equal number of 
significant negative correlations; 
c. With a one-sample t test, assess whether, the mean of the pool of correlations is 






2. Across domains, we will: 
a-b) With2s, compare rate of positive vs negative correlations and the rate of significant 
positive and negative correlations; 
c) With ANOVAS assess differences in the mean size of the correlation among domains 
(Bonferroni correction will be used for post-hoc comparisons). 
 
Before running t-test/ANOVAS, the correlation coefficients will be Fisher Z transformed, 
as it is recommended (see Press, Teukolsky, Vetterling, & Flannery, 1992).   Note that analyses 
which compare number/size of pools of correlations are standard in some field of investigation, 
although not used so far in the PKU literature (see neuroimaging studies; e.g. Boccia et al., 2019; 
Evans & Davis, 2015; Kriegeskorte, Mur, & Bandettin, 2008; Long et al., 2008; Smyser et al., 




Cognitive Abilities.  Results are presented in Table 2. AwPKU had a full-scale IQ in the 
average range (only one patient showed signs of impairment), but significantly lower than 
matched controls.  
--------------------------------- 
Insert Table 2 about here 
---------------------------------- 
 
 Considering the whole neuropsychological assessment together, our PKU sample showed a 






very different for different functions.   The areas showing most substantial difficulties were: 1. 
speed of processing which showed a systematic group difficulty across cognitive tasks (language 
and visuo-spatial attention); 2. complex executive functions and 3. visuo-motor coordination.  
The PKU sample showed also some difficulties in short-term memory.  Performance in sustained 
attention was not statistically different from that of controls, but this may be due to the smallness 
of the sample size.   No group difficulties were found in inhibitory control, verbal learning and 
memory, visuo-spatial learning and memory, and accuracy measures across verbal and visuo-
spatial tasks, with the exception of spoken language accuracy  
Results for Emotion Recognition, Emotional Health, and /Physical Health-related Quality 
of Life are reported in Table 3.   
 
--------------------------------- 
Insert Table 3 about here 
----------------------------------  
 
Emotional Health and mental health-related quality of life.  Scores on the BDI-II did 
not differ from controls. Indeed, only one of the 34 AwPKU (=2.9% of the sample) scored in the 
‘moderate depression’ range and one in the ‘severe depression’ range (=2.9% of the sample).  
Scores on all the subscales of the Interpersonal Reactivity Index (IRI) and of Mental health-
related quality of life scale also did not differ from controls. 
Emotion Recognition.   AwPKU were as accurate as controls in recognizing faces 
(Identity Discrimination) or discriminating emotions (Three Faces Test and Select Affect Test), 






 Physical health-related quality of life.  There were no significant differences from 
controls in terms of Physical Health-related Quality of Life. 
 
Associations between Cognitive Abilities and Emotional Health/ 
Physical health-related quality of life 
 Correlations in the PKU group between our cognitive indices on the one hand and 
emotion recognition, emotional health and physical health-related quality of life, on the other are 
shown in Table 4.  
 
---------------------------------- 
Insert Table 4 about here 
--------------------------------- 
 
Cognitive Abilities and Emotional Health/ mental health-related quality of life. In the 
PKU group, results showed no association between cognitive measures and measures of 
emotional health/ mental-health related quality of life.  Out of 108 correlations, only 52% were 
positive (better cognition better emotional health) which is not statistically different from chance 
(56/108; 2 = .02; p = .89).   There were only a few significant correlations (n = 13) and a similar 
number was positive or negative (8 vs. 5 2 = 2.45; p =. 12).  Finally, the overall average 
correlation was close to 0 (r = .01; one-sample t-test; t(107) = .55; p = .58).  With the IRI Empathy 
scale, there were eight significant, positive correlations (a higher desirable trait with better 
cognition), and two significant negative correlations.  With the Quality of life scale, there was a 






Correlations between cognitive measures and measures of emotional health/ mental 
health-related quality of life were similarly limited in the control group. Out of 108 total 
correlations, 59 were negative and 49 were positive (2 = .32; p = .57).  Only very few 
correlations were significant: two positive (between Verbal Memory and Fantasy; r = 0.42; p = 
.03 and between Verbal Memory and Social Functioning; r = 0.36; p = .05 ) and two negative 
(between Distress and Verbal Learning and Memory; r= -0.39; p = .04; and between Sustained 
attention and Social Functioning; r = -0.39; p < .03).  The overall average correlation was close 
to 0 (r = -.01; one-sample t-test: t(107)= .63; p = .53) and correlation coefficients between 
cognitive functions and emotional health were no different in the two groups (t(214)= .03; p = 
.97).  
Cognitive Abilities and Physical health-related quality of life.  In the PKU group, there 
were widespread correlations between cognitive measures and measures of physical health, 
indicating that AwPKU who performed better in cognitive tasks also enjoyed a better quality of 
life related to physical health.  Out of 48 correlations, 98% were positive (47/48; 2 = 57.4; p < 
.001) and out of the significant correlations, 100% were positive (23/23; p < .001 Fisher's exact 
test).   The overall average correlation was r=.34 which is significantly different from 0 (one-
sample t-test: t(47)= 11.6; p < .001).  Significant correlations were scattered across all the 
subscales, but were more prevalent in the subscales measuring Physical Functioning (which asks 
about limitations in vigorous and moderate activities, such as lifting objects, participating in 
strenuous sports, climbing stairs and walking different distances), Physical Health, which asks 
about effects on working life and Bodily Pain. There were only two significant correlations in 
the General Health subscale which asks for feeling of being healthy compared to others and 






In contrast, in the control group, there was only one significant, negative correlation 
between STM and Physical Function (r = -0.58; p = .001) and the average of the correlation 
coefficients was close to 0 (r = .01; one-sample t-test: t(47) = .15; p = .88).  Therefore, although 
both the PKU and the control group were generally in good health, correlation coefficients 
between cognitive functions and physical health were significantly higher in the PKU group than 
in the control groups (t(94)= -8.88; p < .001) and only in AwPKU cognition and physical health 
were associated with one another.   
 
Associations with Phe Measures 
Table 5 shows correlations between Phe measures at different ages on the one hand, and 
cognitive measures on the other (FSIQ and our composite cognitive scores; emotion recognition 
is not included given that it is not impaired and not associated with measures of 
cognitive/emotional or physical health).  Table 6 shows correlations between Phe concentrations 
at different ages on the one hand, and measures of emotional and physical health on the other.   
 
---------------------------------------- 
Insert Table 5 and 6 about here 
--------------------------------------- 
 
Cognitive measures.  Out of all 91 correlations, 89% were positive (81/91; 2 = 34; p < 
.001); better cognition was associated with better metabolic control.  There was a high number of 
significant correlations and out of them, 100% were positive (30/30; p < .001 Fisher's exact test) 
indicating better cognition with reduced Phe levels. Out of 30 significant correlations 6 were 






average overall r correlation coefficient was 0.25 which is significantly different from 0 (one-
sample t-test: t(83) = 11.22; p < .001) 
Emotional health/ mental healt-related quality of life. Out of 63 correlations, only 41% 
were positive which is not statistically different from chance (26/63; χ2 = 1.3; p = .25). There was 
a small number of significant correlations and most were negative (4/5), that is, better metabolic 
control was associated with more emotional difficulties.  The average overall r correlation 
coefficient was -.06 which is significantly different from 0, but in the direction opposite to that 
expected (better mental health, worse metabolic control; one-sample t-test: t(62) = -2.8; p = .04).  
With the IRI, lower Phe level in childhood and adolescence were associated with 1. a lower 
tendency to adopt someone else’s point of view (Perspective scale2); and 2. more anxiety and 
discomfort from observing another person's negative experience (Personal Distress scale).  There 
was only one significant, positive correlation: lower Phe fluctuations in adulthood was associated 
with more Vitality.   
Physical health-related quality of life.   Out of 28 correlations, 86% were positive: better 
physical health was associated with lower Phe levels and reduced fluctuations (24/28; χ2(1) = 
28.1; p =.001). There was a high proportion of significant correlations (13/28 = 46%) and, out of 
them, 100% were positive (13/13; p < .001 Fisher's exact test).  The average overall r correlation 
coefficient was .30 which is significantly different from 0 (one-sample t-test: t(27)= 6.23; p < 
.001).  
Comparisons across domains.  Chi-square analyses showed that more significant, 
positive correlations were obtained between metabolic variables and either cognitive or physical 
health measures than between metabolic variables and measures of emotional health (33% and 
                                                          







46% vs 1.6%; χ2 = 31.2 and 50.7, respectively; p < .001 for both).  A three-way ANOVA with 
domain as the independent variable (Cognition, Emotional-health/ mental health-related quality 
of life, Physical health-related quality of life) and correlation coefficient with Phe measures as 
the dependent variable showed a highly significant difference (F(2,12) = 26.50; p <.001; ηp2 = 
.82). Post-hoc comparisons, after Bonferroni correction, showed that the strength of the 
correlation with Phe measures was significantly higher for the physical health and cognitive 
measures than for the emotional health measures (p  < .01). Instead, the strength of the 
correlation between Phe measures and either physical health or cognitive measures was not 
significantly different (p  = .91). 
 
Attitudes Towards Diet 
We evaluated attitudes towards the PKU diet with two questions to be answered using a 
seven 7-point Likert scale.  We asked: 1. “How important is it for you to follow the diet?”  with 
responses ranging from 1 (not important at all) to 7 (very important); and 2. “How easy is it for 
you to follow the diet?” with responses ranging from 1 (not easy at all) to 7 (very easy). In 
response to question 1, the average score was 5.9 (SD =1.2; range: 3-7), indicating that most 
participants thought it important to follow the diet.  In response to question 2, the average score 
was 4.6 (SD =1.6; range: 1-7), indicating that on average participants found relatively easy to 
follow the diet, but variability was high.  Table 7 shows correlations between attitudes towards 
diet and measures of emotional health and physical health.  There was a lack of significant 
correlations between how important it is deemed to be on diet.  However, there were two 
significant correlations with ease of keeping to the diet.  The easier our participants found being 












We evaluated emotional health, physical health and cognitive abilities in a sample of 
adults with PKU, as well as their inter-relations and relations with Phe measures.  We had 
described cognitive performance in an overlapping sample of AwPKU in previous publications 
(Palermo et al., 2017; Romani et al., 2017). Here we report relationships with emotional health 
and physical health measures.  AwPKU had a full-scale IQ in the average range, but significantly 
lower than that of controls matched for education3.  This result is consistent with previous 
studies and suggest that AwPKU do not reach their full potential (see also DeRoche & Welsh, 
2008; Moyle, Fox, Arthur et al., 2007 for a meta-analysis). 
 Considering the whole neuropsychological assessment together, as a group, AwPKU 
performed well in a variety of cognitive domains, but also showed specific deficits, mainly 
involving speed of processing (in visuo-spatial tasks, language tasks, tasks involving emotional 
recognition) and executive functions (EFs) such as planning, reasoning and monitoring (poor 
performance on Tower of Hanoi, WCST, semantic fluency, Trail-making test, Similarities of the 
WASI, STM tasks).  Performance was also poor in tasks involving visuo-motor coordination 
such as the peg-board task and the digit symbol tasks (which also taps EFs). Performance in 
sustained attention was not statistically different from that of controls, but this may be due to the 
smallness of the simple size since significant results were found in Palermo et al. (2017) with a 
                                                          
3 . The control group had an average IQ above 100, but this is expected given that participants 






larger sample that included six more participants and with a mixed English and Italian sample 
(see Romani et al., in press).   No group difficulties were found in inhibitory control, verbal 
learning and memory, visuo-spatial learning and memory, and accuracy measures across verbal 
and visuo-spatial tasks, with exception of spoken language accuracy where the index includes 
tasks with a strong abstract reasoning component and/or strongly related to general intelligence 
(Similarities and Vocabulary and form the WASI; Jensen, 2001; McCrimmon & Smith, 2013).   
  Variability, however, was high, with about 1/3 of participants showing average or above 
average performance (see Palermo et al., 2017 for more details).  Cognitive capacities were 
modulated by Phe levels and Phe fluctuations.  Constancy in maintaining a diet was, if anything, 
more important than average levels since fluctuations had an even stronger negative effect on 
performance (see also Cleary et al., 2013; Romani et al., in press).   
As a group, AwPKU showed no evidence of ill physical health, with self-reported scores 
of quality of life related to physical health being very similar to those of the controls.  However, 
variations in physical health correlated with cognition in the PKU group, but not in the control 
group.  This is likely to be due to that in AwPKU both physical health and cognitive abilities are 
mediated by an intermediate variable which is blood Phe. In fact, in our sample, AwPKU with 
lower Phe levels enjoyed both better cognition and better physical health, this result being 
consistent with reports of more medical issues, such as headaches, eczema and neurological 
signs, in participants who relax the diet compared with participants on diet (see Koch et al., 
2002).  It is unlikely that causation would be in the opposite direction (less subjective physical 
health, less ability to keep on the diet) because we found no relation between the physical health 
related quality of life questionnaire and our question concerning how easy it was to keep on diet.  
Taken together, these results make a case for maintaining low Phe levels through life (see 






adulthood; in this study, older patients who relaxed the diet in adolescence showed worse 
cognitive performance than younger patients who maintained better control although differences 
could also be due to poorer treatment options/support available for the older patient which were 
treated in the 1970s and 80s). 
As a group, our PKU participants showed no significant difficulties in emotional 
recognition accuracy. They were slower that controls in discriminating emotions, but they were 
also slower in the identity discrimination task which does not involve emotional processing, 
suggesting a general speed reduction in processing of visuo-perceptual stimuli rather than 
specific difficulties in processing emotions (see also Romani et al., 2017).   They also showed no 
increased symptoms of depression, a good ability to show empathy and no problems with quality 
of life related to emotional health.  Moreover, when compared to controls matched for gender 
and education, they showed the same incidence of individuals in a stable relationship and/or with 
children, and no difference in income for those employed.  Our sample is too small to derive 
strong demographic conclusions. Nevertheless, taken together, our results suggest that, as a 
group, early treated AwPKU function very well (see also Bosch et al., 2007 and Simon et al., 
2008 for similar results showing good quality of life, social capacity and sociodemographic 
outcomes in AwPKU).   
Our results are consistent with those of previous studies that also reported no emotional 
difficulties in AwPKU (mainly on UK samples of patients: see Channon et al., 2004; 2005; 
2007), but at odds with other studies which, instead, detected some emotional difficulties both in 
early treated children and adults with PKU (e.g., Jahja et al., 2017a,b; Manti et al. 2016; Pietz et 
al., 1997).   There could be different possibilities of these discrepancies.  First of all, we should 
note that the range of possible difficulties that we measured was limited.  For example, we did 






AwPKU compared to others described in the literature (average Phe level at testing time 670 
µmol/L) which may have limited the scope for impairment.  Alternatively, presence/absence of 
emotional difficulties may be due to differences in clinical management across centres with 
different levels of psychological support received by the patients and/or to socio-cultural 
differences in style of parenting and in the centrality of food for socialization.  It is also possible 
that in PKU some genetic mutations, but not others are linked to emotional difficulties.  This is 
very speculative, but the mutation R261Q is relatively prevalent in the Netherlands (for a review 
see Zschocke, 2003), and studies with Dutch patients seem to report more mental difficulties 
than studies on other populations. 
We have found no positive association between measures of emotional-health and either 
cognitive abilities or measures of metabolic control.  Relationship with cognitive abilities have 
not been assessed before. Importantly, there were no significant correlations between cognition 
and the depression questionnaire.  This suggests that in our participants depression had no role in 
reducing speed of processing and/or in affecting executive functions.  Overall, we found a small 
negative correlation between emotional health and metabolic control (-.06) which was 
significantly different from 0 and a small number of significant individual negative correlations 
(4/5), indicating more emotional difficulties with better metabolic control. There was only one 
significant, positive correlation between Phe fluctuations in adulthood and Vitality.  Vitality, 
however, is strongly related to physical health (see Ware, Kosinski, & Keller, 1994) and thus, 
this correlation fits with the widespread correlations between Phe levels and physical health 
discussed above.  These results are marginal, but they point to the emotional costs of keeping on 
a strict life-long diet. 
Other studies have found no positive relation between emotional health and metabolic 






been exceptions (e.g., Bilder et al., 2013).   As customary, we have assessed emotional health 
through self-report questionnaires and it is also possible that people with better metabolic control 
are more aware and better able to report difficulties than people with worse control, cancelling 
some differences out.  However, our comparisons of patterns of correlations across domains 
clearly indicates that the impact of metabolic control on the emotional domains examined is 
much weaker than on cognitive abilities and physical health.  We can speculate that the 
dopaminergic pathways involved in emotional processing (the mesolimbic pathway, which 
connects the ventro-tegmental area to the limbic system) is less sensitive to dopamine depletion 
that the pathways involved in cognitive processing (the mesocortical pathway, which connects 
the ventro-tegmental area to the prefrontal cortex; see Wise, 2004; but see Björklund & Dunnett, 
2007 for anatomical overlap of these networks).  If so, a relation between Phe level and 
emotional health would emerge only in a sample of participants with higher Phe concentrations 
than our own.   
Finally, one should consider, that emotional difficulties, whenever present, may be 
related more to the stress of living with a chronic disease or a restrictive/controlling style of 
parenting than to high levels of Phe (see also Pietz et al., 1997; Manti et al., 2016). Higher scores 
in perspective taking are indicative of adaptive and prosocial affective responses (Batson, Fultz, 
& Schoenrade, 1987; Batson et al., 1997).  In our sample, a better ability to take other people’s 
perspectives and less distress in emotionally tense interpersonal situations were associated with 
higher Phe levels and, therefore, less dietary control in childhood and adolescence.  It is possible 
that those who find harder to keep on a diet (and have less dietary control) develop more 
empathy for others. It is also possible that those who have a more relaxed approach to diet have a 
better socialization and less social anxiety.  Keeping a strict diet may be particularly difficult in 






found that those who reported harder to keep on a diet had worse emotional well-being (although 
this relation could also suggest that, vice-versa, the presence of emotional difficulties can make 
harder to adhere to the diet).  The diverse emotional reactions caused by keeping a PKU diet are 
well exemplified by the different answers given by two of our PKU participants when we asked 
them to provide any comments about the diet as part of our Attitudes Toward Diet 
Questionnaire.  Participant A, who decided to resume the diet after stopping it for a while said: 
“When I was off diet I felt like a monster. I was depressed and anxious”.  Participant B, who 
decided to stop the diet said; “I felt worse on diet, very awkward at work and I was very low”. 
These considerations underline the difficulties for some AwPKU to stay on diet and highlight the 
importance of developing alternative therapies to offer to the people with PKU more options of 
treatment (e.g., enzyme substitution therapy; see Pascucci et al., 2018; Thomas et al., 2018). 
In conclusion, we found that cognitive measures and measures of quality of life related to 
physical health were strongly associated to dietary control in our sample of early-treated adults 
with PKU.  In contrast, we found no evidence that emotional difficulties are a core issue in this 
population and only limited (and negative) associations with metabolic control.  These null 
results could have several causes, but they highlight that cognitive measures are more sensitive 
indicators of outcomes related to dietary control than emotional health measures. More 
speculatively, our results indicate that, in some adults with PKU, the stress of being on a diet 
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Note: Phe levels and Phe fluctuations across an age band were calculated by averaging year 
averages for each patient and then averaging values across the group.  The SDs refer to 
differences between the participants’ averages. Fluctuations were calculated in terms of SD of 





 Controls   PKU Group   PKU vs Controls 


















2.1 36  t(1,74)= 0.9; p=.37 
Gender (M/F) 10/30  40  13/23  36  χ2(1)= 1.1; p=.29 
% Unemployed  10.0  30  14.7  34  χ2(1)= 0.3; p=.57 
Salary £28822 11662 17  £23845 12025 26  t(1,41)= 1.3; p=.19 
          
0-10 Years old          
N of blood samples     189 67    
Phe Level (per year)     436 192 29   
Phe Fluctuations (per year)     189 102 29   
          
11-16 Years old          
N of blood samples      74 69    
Phe Level (per year)     670 315 33   
Phe Fluctuations (per year)     146 53 33   
          
17 years old to present          
N of blood samples      60 60    
Phe Level (per year)     747 304 36   
Phe Fluctuations (per year)     135 53 36   
          






Table 2. Cognitive performance in control and PKU participants.  Performance for different 
composite scores is reported in terms of z-scores (the higher z-score the worse the performance). 
* indicates significant differences also after Bonferroni correction (.05/14 = .004). g= Hedges' g 




Note.  Complex EF: The Tower of Hanoi puzzle; The Wisconsin Card Sorting Test; Semantic 
Fluency; Trail Making Test B-A; Visuo-spatial attention - speed: Simple Detection; Detection 
with distractors; Opposite Detection with distractor; Choice Reaction Time; Feature Search; 
Language production- speed: Word Reading; Nonword Reading; Picture Naming; Colour 
Naming. Visuo-motor coordination: Digit Symbol; Grooved Pegboard Test; STM: Digit Span; 
Nonword Repetition; Corsi Block Span; Sustained attention: Rapid Visual Information 
Processing (RVP); Inhibitory control:  Stroop interference; Picture naming interference;  Visuo-
spatial attention - accuracy: same task but in terms of accuracy (simple Detection excluded 
because of lack of errors; Orthographic processing – accuracy: Word reading and Nonword 
reading; Word Spelling and Nonword spelling; Phoneme deletion; Spoonerisms; Spoken 
language - accuracy: Picture naming; Color naming; Similarities; Vocabulary; Visuo-spatial 
learning and memory: Delayed Matching to Sample; Paired Associates Visual Learning; Verbal 
learning and memory: The Rey Auditory Verbal Learning Test  
  Control   PKU Group   PKU vs. Controls 
 Mean SD n  Mean SD n    t-test and p 
 
            
FSIQ  113.4 10.1 40  104.3 14.2 36  t(1,74)= 3.2; p=.002*; g=0.71 
        
 
Complex EF 0 0.6 30  0.8 1.2 31  t(1,59)= -3.4; p=.001*; g=-0.83 
Visuo-spatial attention -speed 0 0.7 30  0.8 1.3 31  t(1,59)= -3.1; p=.003*; g=-0.75 
Language – speed 0 0.8 30  1.1 1.5 29  t(1,57)= -3.4; p=.001*; g=-0.91 
Visuo-motor coordination 0 0.8 30  1.0 1.5 31  t(1,59)= -3.2; p=.002*; g=-0.82 
STM 0 0.7 30  0.5 0.8 31  t(1,59)= -2.7; p=.009; g=-0.66 
Sustained attention 0 1.0 30  0.4 1 31  t(1,59)= -1.4; p=.17; g=-0.39 
Inhibitory control 0 0.4 30  0.3 0.7 30  t(1,58)= -1.6; p=.11; g=-0.52 
Visuo-spatial attention -accuracy 0 0.6 30  0.0 0.6 31  t(1,59)= -0.1; p=.95; g= 0 
Orthographic process. – accuracy 0 0.7 30  0.1 1.1 30  t(1,58)= -0.5; p=.59; g= -0.11 
Spoken language – accuracy 0 0.7 30  0.5 1.1 31  t(1,59)= -2.2; p=.03; g= -0.53 
Verbal Learning and memory 0 0.8 30  0.0 0.8 30  t(1,58)= 0.1; p=.91; g= 0 
Visuo-spatial learning and 
memory 
0 0.7 30  0.5 1.4 31  t(1,59)= -1.6; p= .11; g= -0.44 






Table 3.   Emotion recognition, emotional health/ mental health-related quality of life, and 
physical health-related quality of life in control and PKU participants.  
 
 
Note. For emotion recognition, speed was measured in seconds; a composite z-score averages 
speed and accuracy z-scores in the 3 Faces Test and the Affect Selection Test. For consistency 
across tasks, a higher z-score always reflect worse performance. No differences are significant 








 PKU Group 
 
PKU vs. Controls 
 












BDI-II – Depression 7.5 8.7 39  7.5 7.2 0.0 35  t(1,72)= .04; p=. 97; g= 0 
IRI – Empathy           
Perspective-Taking 18.4 4.0 37  18.7 4.0 - 0.1 30  t (1,65)= -0.3; p=.78;  g= -0.07 
Fantasy 15.1 6.3 37  13.9 5.7 0.2 30  t (1,65)= 0.8; p=.42; g= 0.19 
Empathic Concern 19.4 3.5 37  20.3 3.4 -0.3 30  t (1,65)= -1.1; p=.26;  g=- 0.26 
Personal Distress 11.3 4.6 37  10.1 5.1 -0.3 30  t (1,65)= 1.0; p=.32;  g= 0.24 
          
SF-36 QoL- Mental Health          
Vitality 53.8 16.5 30  60.0 20.6 -0.4 31  t (1,59)= 1.3; p=.19;  g= -0.33 
Social functioning 90.1 18.9 30  88.7 14.9 0.1 31  t (1,59)= -.3; p=.75;  g= -0.08 
Limitations-emotional health 80.0 35.7 30  79.6 35.1 0.0 31  t (1,59)= -.05; p=.96;  g= 0.01 
Emotional well-being 71.3 15.8 30  75.2 15.5 0.2 31  t (1,59)= 1.0; p=.33;  g= -0.25 
           
EMOTION RECOGNITION          
Identity Test – Speed 2.2 0.7 25  2.8 1.1 0.9 20  t (1,43)= -2.3; p=.024; g= -0.66 
Identity Test – Accuracy 21.4 1.0 25  21.5 0.7 -0.1 20  t (1,43)= -.39; p=.70;  g= -0.11 
3 Faces Test – Speed  4.5 1.9 25  5.5 2.0 0.5 20  t (1,43)= -1.7; p=.09;  g= -0.51 
3 Faces Test – Accuracy 22.6 4.8 25  23.1 2.9 -0.1 20  t (1,43)= -0.45; p=.66;  g= -0.12 
Affect Selection - Speed  4.7 1.3 25  5.6 1.2 0.7 20  t (1,43)= -2.5; p=.018; g= -0.70 
Affect Selection – Accuracy 18.2 2.0 25  18.5 2.0 -0.1 20  t (1,43)= -0.44; p=.66;  g= -0.15 
 z emotion recognition Speed 0.0 0.9 25  1.0 0.7  20  t (1,43)= -2.5; p=.017; g= -0.73 
 z emotion recognition Accuracy 0.0 0.7 25  0.6 -0.1  20  t (1,43)= 0.6; p= .55;  g= 0.15 
          
PHYSICAL HEALTH           
SF-36 QoL- Physical Health           
Physical function 96.2 8.8 30  93.9 17.6 0.3 31  t (1,59)= 0.6; p= .53;  g= 0.16 
Limitations - physical health  94.2 20.4 30  91.1 26.3 0.1 31  t (1,59)= 0.5; p=.62;  g=0.13 
Bodily pain 85.3 17.8 30  87.2 16.3 -0.1 31  t (1,59)= 0.4; p=.66;  g= -0.11 






Table 4. Correlations between cognitive measures on the one hand (IQ, composite indexes and emotion recognition), and emotional health/ mental-health-
related quality of life and physical health-related quality of life on the other.  







 SF36 QoL 






























FSIQ .10 .03 .08 -.13 .17  .22 .02 -.15 -.08  .60** .58** .50** .46** 
N 35 30 30 30 30  31 31 31 31  31 31 31 31 
Composite cognitive scores               
Complex EF -.29 -.13 .11 -.04 -.11  .09 -.24 -.44* -.11  .37* .28 .37* .02 





.51** .21 .24  .17 .05 .06 -.01  .15 .43* .38* .31 
Visuo-motor coordination -.10 .06 .47* .24 -.20  .18 -.20 -.21 -.16  .64** .58** .33 .13 
STM .20 .21 .48* .05 .54**  .28 .02 -.06 -.05  .53** .54** .28 .46* 
Sustained attention .01 .02 .08 .13 -.17  .16 .07 -.01 .15  .32 .36* .37* .25 
Inhibitory control -.09 -.10 .36 -.11 .10  -.14 -.39* -.23 -.29  .22 .26 .22 -.07 
Visuo-spatial atten. -accuracy .04 .04 -.21 -.02 -.20  .18 .02 .20 .37*  .25 .21 .09 .13 
Orthographic process. - 
accuracy 
.14 .40* .41* .17 .32  .09 .02 .21 .08  .21 .38* .31 .32 
Spoken language -.07 -.12 -.10 -.07 .06  .16 -.32 -.29 -.20  .74** .67** .40* .19 
Verbal learning and memory -.08 .06 .09 .07 -.44*  .28 -.03 -.14 .05  .38* .29 .40* .21 
Visuo-spatial learn. and memory -.20 -.42* .02 -.05 -.47*  .16 -.25 -.24 -.10  .57** .45* .54** .08 
n # 31 26 26 26 26  30 30 30 30  30 30 30 30 
Emotion Recognition 
     
         
Speed .23 .28 .48  -.09 .48  
 
.09 .13 .39 -.13      
Accuracy -.07 .26 .05 -.08 .11 
 








Note: For consistency, across tasks, positive correlations always indicate that better cognitive skills were linked to better health.  For example, negative 
correlations with verbal memory and learning indicate that those with better memory did worse on some heath measures; positive correlation between FSIQ and 
BDI-II indicates that better the IQ better the mental health on the depression dimension (i.e., lower the depression). 
Significant correlations are in bold.   **p<.01 *p<.05.  
 
n 19 16 16 16 16   15 15 15 15          
52 
 
Table 5. Correlations between cognitive measures (IQ, cognitive composite scores, emotion 
recognition) on the one hand and Phe measures (average levels and fluctuations) on the other.  
 
 
Note. To facilitate interpretation, positive correlations indicate that high Phe was related to worse 
performance. Thus, in the case of the IQ, as Phe increased, IQ decreased.  
Note the number of AwPKU is slightly different across tests (see table 2), as is the number of 
Phe measures available (see table 1); this means that the same value of r may have different 




Average Phe levels 
 




















FSIQ .26 .13 .24 .24  .41* .46** .43** 
         
Cognitive composite scores         
Complex EF .36 .32 .27 .28  .51** .42* .21 
Visuo-spatial attention – speed .53** .32 .33 .07  .45* .16 .36* 
Language – speed .11 .04 .20 -.02  .05 -.01 .01 
Visuo-motor coordination .34 .23 .34 .41*  .42* .43* .39* 
STM .10 -.05 -.05 -.23  .10 .21 .23 
Sustained attention .17 .04 .15 .32  .08 .01 .26 
Inhibitory control .18 -.02 -.04 .08  .17 .34 .18 
Vsuo-spatial attention - accuracy .21 .16 .34 .34  .42* .51** .36* 
Orthographic processing - accuracy -.01 -.18 .01 -.02  .03 .14 .16 
Spoken language .33 .08 .11 .16  .44* .53** .56** 
Verbal learning and memory .23 .38* .45* .63**  .44* .40* .19 
Visuo-spatial learning and memory .51** .58** .40* .38*  .62** .45* .54** 
         
Emotion Recognition         
Speed -.05 -.08 .32 -.03  .02 -.18 .23 
Accuracy -.14 -.30 -.11 -.15  .16 .28 .15 
53 
 
Table 6. Correlations between emotional health/ mental-health-related quality of life and physical 
health-related quality of life measures on the one hand, and Phe measures (average levels and 
fluctuations) on the other.  
 
Note. To facilitate interpretation, positive correlations indicate that high Phe was related to 
reduced mental/physical health.  Thus, in the case of the BDI, perspective taking and personal 
distress, negative correlations indicate that as Phe increased depression and personal distress 
decreased, while perspective-taking increased. Significant correlations are in bold.  **p<.01 
*p<.05. 
  
Average Phe levels 
 

















         
EMOTIONAL/MENTAL 
HEALTH        
 
BDI-II Depression -.16 -.07 .12 .02  -.30 -.21 .28 
IRI Empathy         
Perspective-Taking -.49* -.54** -.10 -.07  -.24 .09 -.30 
Fantasy -.26 -.05 .13 -.04  -.15 .04 .32 
Empathic Concern -.24 -.16 0 .17  -.01 -.11 -.23 
Personal Distress -.32 -.52** -.29 -.51**  -.34 -.06 .02 
SF-36 QoL Emotional Health       
Vitality .10 .24 .21 -.11  .27 .28 .39* 
Social functioning -.18 -.04 .06 .01  -.26 -.17 .20 
Emotional limitations -.13 -.05 .11 0  -.24 -.16 .26 
Emotional well-being -.03 .14 .16 .13  -.13 -.07 .05 
         
PHYSICAL HEALTH        
SF-36 QoL Physical Health        
Physical functioning .48* .20 .37* .03  .57
** .51** .71** 
Physical limitations .55** .21 .42* -.04  .55
** .39* .62** 
Bodily pain .36 .36 .40* .14  .38 .17 .50** 




Table 7. Correlations among metal health (BDI and IRI), health-related quality of life (SF-36) 



















Note.  **p<.01 *p<.05. Highlighted correlations are significant at p<.01. 
 
. 
  Importance of 
Diet 
Ease to 
 Keep on Diet    
EMOTIONAL HEALTH   
BDI-score -.13 -.39* 
n 29 29 
IRI-score   
 Perspective-Taking .10 .13 
 Fantasy -.01 .19 
 Empathic Concern .29 .12 
 Personal Distress .21 .04 
n 24 24 
SF-36-score – Mental health   
 Vitality -.06 .21 
 Social functioning -.06 .34 
 Limitations emotional 
health 
.09 .28 
 Emotional well-being .27 .51** 
n 28 28 
PHYSICAL HEALTH    
SF-36-score – Physical health   
 Physical functioning .08 -.02 
 Limitations physical health  .18 -.03 
 Bodily pain .25 .10 
 General health -.08 .27 
n 28 28 
